Cure8 research brief
Non-invasive imaging biomarkers that track intestinal inflammation and structure could speed preclinical testing of IBD therapies and guide translational imaging research relevant to clinical monitoring of ulcerative colitis.
Researchers, preclinical scientists, radiologists, and clinicians interested in imaging-based biomarkers for IBD.
This paper describes a preclinical study using a rat model of dextran sulfate sodium (DSS)-induced ulcerative colitis to test a multimodal imaging approach (MRI, micro-CT, and high-frequency ultrasound).
The authors measured imaging biomarkers such as bowel wall thickness, luminal diameter, edema volume, vascularity index, and motility across colon regions and compared them with gross pathology and histology.
The multimodal model reportedly produced very strong diagnostic performance in this experimental setting and high inter-observer reproducibility, with different modalities contributing complementary information (MRI for soft tissue, micro-CT for 3D structure, ultrasound for dynamic function and perfusion).
This work is focused on a preclinical platform for non-invasive longitudinal monitoring and for evaluating therapies in animal studies; it does not report clinical trials or patient data. The findings are presented as validation against histology and gross pathology in rats, not as direct evidence for changes in clinical practice or patient care.
Study uses a DSS-induced rat model and compares imaging findings to pathology and histology; results reflect preclinical validation, not human clinical outcomes.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The probe targets azoreductase-driven hypoxia, a mechanism linked to ulcerative colitis and other hypoxia-associated diseases; a reliable real-time imaging method could help research and eventually guide treatments.
Patients and clinicians struggle to predict relapse in ulcerative colitis because current endoscopic, histologic, and noninvasive biomarkers are imperfect. A tissue-based imaging and spatial-omics approach could identify...
A new chemiluminescent probe may help researchers detect and visualize peroxynitrite, a reactive species linked to inflammation in ulcerative colitis, which could aid research into disease mechanisms and early detection...
